U.S. FDA Approves Novocure's Optune Pax(R) for the Treatment of Locally Advanced Pancreatic ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax (R) for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...
MassDevice

Novocure wins FDA nod for Optune Pax as pancreatic cancer treatment

Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.
gearpatrol

Pax Plus Review: Setting a New Standard for Weed Vaporizers

Rather than resting on their laurels, however, the folks at Pax were actually hard at work crafting some new offerings, including both a new portable vape called the Pax Mini, and (perhaps more ...